Kröger, N <br/><br/>
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.  [electronic resource] 

 -  Bone marrow transplantation  Oct 2001 
 - 643-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1703215  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anemia, Refractory, with Excess of Blasts--genetics<br/>Antilymphocyte Serum--administration & dosage<br/>Bone Marrow--pathology<br/>Busulfan--administration & dosage<br/>Cell Count<br/>Chromosomes, Human, Pair 7--genetics<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Feasibility Studies<br/>Graft Survival<br/>Graft vs Host Disease--mortality<br/>Hematopoietic Stem Cell Transplantation<br/>Hepatic Veno-Occlusive Disease--etiology<br/>Histocompatibility<br/>Humans<br/>Infections--etiology<br/>Karyotyping<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Monosomy<br/>Myelodysplastic Syndromes--genetics<br/>Recurrence<br/>Survival Rate<br/>T-Lymphocytes<br/>Tissue Donors<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Vidarabine--administration & dosage